Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
TOBU RAILWAY, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 2%
9001 TOBU RAILWAY CO.,LTD. 【J-GAAP】
Earnings ReportTOBU RAILWAY CO.,LTD. <9001> [TSE Prime] announced its financial results after the market closed on February 5th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) was 58.9 billion yen, a 2.3% decrease compared to the same period last year. The progress rate toward the full-year plan of 65 billion yen was 90.7%, also surpassing the five-year average of 83.4%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to drop 48.2% from the same period last year to 6.05 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit amounted to 21.5 billion yen, a 2.5% decrease compared to the same period last year. However, the operating profit margin remained almost flat, changing from 14.1% in the same period last year to 14.1%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 447,336 | 45,461 | 44,230 | 28,273 | 135.5 | 80.7 | Feb 8, 2023 | J-GAAP |
Apr - Dec, 2023 | 466,718 | 61,406 | 60,335 | 40,914 | 197.9 | 83.8 | Feb 7, 2024 | J-GAAP |
Apr - Dec, 2024 | 458,477 | 60,589 | 58,945 | 41,832 | 205.2 | 90.7 | Feb 5, 2025 | J-GAAP |
YoY | -1.8% | -1.3% | -2.3% | +2.2% | +3.7% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 327,382 | 34,796 | 33,833 | 21,789 | 105.4 | 30 | Apr 30, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 337,004 | 29,522 | 27,626 | 23,161 | 116.0 | 27.50 | Nov 6, 2024 | J-GAAP |
YoY | +2.9% | -15.2% | -18.3% | +6.3% | +10.1% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 614,751 | 56,688 | 54,815 | 29,179 | 140.1 | 30 | Apr 28, 2023 | J-GAAP |
Mar, 2024 | 635,964 | 73,883 | 72,033 | 48,164 | 233.0 | 55 | Apr 30, 2024 | J-GAAP |
Mar, 2025 Guidance | 639,000 | 68,000 | 65,000 | 48,500 | 243.0 | 55 | Nov 6, 2024 | J-GAAP |
YoY | +0.5% | -8.0% | -9.8% | +0.7% | +4.3% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 158,136 | 22,319 | 22,135 | 14,539 | 70.3 | 14.1 | Feb 7, 2024 | J-GAAP |
Jan - Mar, 2024 | 169,246 | 12,477 | 11,698 | 7,250 | 35.1 | 7.4 | Apr 30, 2024 | J-GAAP |
Apr - Jun, 2024 | 149,914 | 21,396 | 21,600 | 14,891 | 72.0 | 14.3 | Aug 5, 2024 | J-GAAP |
Jul - Sep, 2024 | 152,082 | 17,082 | 15,774 | 10,448 | 50.8 | 11.2 | Nov 6, 2024 | J-GAAP |
Oct - Dec, 2024 | 156,481 | 22,111 | 21,571 | 16,493 | 80.9 | 14.1 | Feb 5, 2025 | J-GAAP |
YoY | -1.0% | -0.9% | -2.5% | +13.4% | +15.0% |
Related Articles
KIKKOMAN, Apr-Dec (Cumulative 3Q) Net Income Increases by 13%
KYORIN Pharma, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 30%, Oct-Dec Ordinary Profit Decreases by 55%
FUJI KYUKO, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 7%
Noevir, Oct-Dec (1Q) Ordinary Profit Decreases by 8%
NIHON KOHDEN, Oct-Dec (3Q) Ordinary Profit Increases by 16 times
AI Inc, Apr-Dec (Cumulative 3Q) Net Income Turns to Loss, Oct-Dec Net Income Turns to Loss
ORGANO, The Current Fiscal Year Ordinary Profit Revised Upward by 9%, Raises Record High Profit Forecast
NISHIO HOLDINGS, Oct-Dec (1Q) Ordinary Profit Increases by 16%
SHOFU, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 22%, Oct-Dec Ordinary Profit Increases by 14%
SBI RHEOS HIFUMI, 11% Increase in Undisclosed Ordinary Profit, Record High for The First Time in Three Years